Brendan Hannah
Director of Finance/CFO presso QUINCE THERAPEUTICS, INC.
Patrimonio netto: 213 648 $ in data 31/03/2024
Profilo
Brendan Hannah is currently the COO, Chief Financial & Accounting Officer at Quince Therapeutics, Inc. and also holds the position of Chief Operating Officer at Novosteo, Inc. Previously, he worked as the Director of Business Development at Cidara Therapeutics, Inc. and as the Chief Business Officer at Neuroptika, Inc. Mr. Hannah obtained an MBA from the University of California.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/02/2024 | 201 555 ( 0.47% ) | 213 648 $ | 31/03/2024 |
Posizioni attive di Brendan Hannah
| Società | Posizione | Inizio |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Director of Finance/CFO | 16/03/2023 |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Chief Operating Officer | - |
Precedenti posizioni note di Brendan Hannah
| Società | Posizione | Fine |
|---|---|---|
| CIDARA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2016 |
Neuroptika, Inc.
 Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formazione di Brendan Hannah
| University of California | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CIDARA THERAPEUTICS, INC. | Health Technology |
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Health Technology |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Health Technology |
- Borsa valori
- Insiders
- Brendan Hannah
